FrancophonIA/ELRC3.0 huggingface dataset:
English: Raloxifene Teva reduces the risk of vertebral fractures in women with postmenopausal osteoporosis.
Croatian: U žena s postmenopauzalnom osteoporozom Raloksifen Teva smanjuje rizik od prijeloma kralježaka.
English: Fewer raloxifene treated women than placebo treated women required surgical intervention for uterine prolapse.
Croatian: Manji broj kirurških zahvata zbog prolapsa maternice zabilježen je u žena liječenih raloksifenom u usporedbi sa ženama koje su uzimale placebo.
English: Musculoskeletal and connective tissue disorders Common: Leg cramps
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva
English: In the RUTH study, leg cramps were observed in 12.1 % of raloxifene-treated patients and 8.3 % of placebo-treated patients.
Croatian: bolesnica koje su liječene raloksifenom i 8,3 % bolesnica koje su dobivale placebo.
English: Pharmaceutical form
Croatian: Farmaceutski oblik Put primjene
English: The recommended dose is one tablet once a day taken with food and at the same time each day.
Croatian: Preporučena doza je jedna tableta dnevno, koja se uzima uz obrok i u isto vrijeme svakoga dana.
English: Further information on Senshio can be found on the Agency's website: www.ema.europa.eu/medicines/human/EPAR/senshio .
Croatian: Više informacija o lijeku Senshio dostupno je na internetskim stranicama Agencije: www.ema.europa.eu/medicines/human/EPAR/senshio .
English: Senshio (ospemifene)
Croatian: Senshio (ospemifen)
English: Senshio is available as tablets (60 mg).
Croatian: Lijek Senshio dostupan je u obliku tableta (60 mg).
English: Senshio received a marketing authorisation valid throughout the EU on 15 January 2015.
Croatian: Lijek Senshio dobio je odobrenje za stavljanje u promet koje vrijedi na prostoru EU-a od 15. siječnja 2015.
English: Since Senshio is given by mouth the Agency considered that this medicine is a valuable alternative for women for whom local treatment is unsuitable.
Croatian: Budući da se lijek Senshio daje kroz usta, Agencija je smatrala da je ovaj lijek vrijedna alternativa za žene koje lokalna terapija nije primjerena.
English: Oestrogen hormones help to maintain the health of tissue in and around the vagina.
Croatian: Hormoni estrogena pomažu održavati zdravlje tkiva unutar vagine i oko nje.
English: Women also received non-hormonal vaginal lubricant for use as needed.
Croatian: Žene su dobile i nehormonski vaginalni lubrikant kojim se mogu koristiti prema potrebi.
English: As the levels of oestrogen hormones fall during the menopause, the vaginal lining may become thin and dry.
Croatian: Budući da se razina hormona estrogena smanjuje tijekom menopauze, vaginalna sluznica može se stanjiti i postati suha.
English: What measures are being taken to ensure the safe and effective use of Senshio?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Senshio?
English: This means that it acts in the same way as oestrogen in some tissues in the body such as the vagina and so helps to reduce symptoms of vulvovaginal atrophy.
Croatian: To znači da djeluje na isti način kao estrogen u pojedinim tkivima u tijelu, kao što je vagina, te time doprinosi ublažavanju simptoma vulvovaginalne atrofije.
English: However, ospemifene does not work in the same way in other tissues such as the breast and womb, where such activity could cause hyperplasia (growth) of tissues which could lead to cancer.
Croatian: Međutim, ospemifen ne djeluje na jednak način u drugim tkivima, kao što su dojke ili maternica, u kojima takvo djelovanje može dovesti do hiperplazije (rast) tkiva, što može prouzročiti rak.
English: What is Senshio and what is it used for?
Croatian: Što je Senshio i za što se koristi?
English: Side effects reported with Senshio are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Senshio pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: The main measure of effectiveness was related to the change in symptoms such as pain associated with sexual activity and vaginal dryness, using a validated questionnaire.
Croatian: Glavno mjerilo učinkovitosti bilo je povezano s promjenom simptoma kao što su bol povezana sa spolnom aktivnošću i vaginalna suhoća, a utvrđeno je putem validiranog upitnika.
English: Other information about Senshio
Croatian: Ostale informacije o lijeku Senshio
English: An overview of Senshio and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Senshio i zašto je odobren u EU-u
English: The studies also showed that Senshio was effective in restoring the vaginal environment including its acidity and thickness of the lining.
Croatian: Ispitivanja su pokazala i da je lijek Senshio bio učinkovit u obnavljanju vaginalnog okruženja, uključujući njegovu kiselost i debljinu sluznice.
English: The European Medicines Agency decided that Senshio's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove zaključila je da koristi od lijeka Senshio nadmašuju s njim povezane rizike te se može izdati odobrenje za njegovu primjenu u EU-u.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Senshio have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Senshio također se nalaze u sažetku opisa svojstava i u uputi o lijeku.
English: For more information about using Senshio, see the package leaflet or contact your doctor or pharmacist.
Croatian: Za više informacija o primjeni lijeka Senshio pročitajte uputu o lijeku, odnosno obratite se liječniku ili ljekarniku.
English: It is used in women who cannot use oestrogen therapy applied in the vagina.
Croatian: Koristi se u žena koje ne mogu primati estrogensku terapiju koja se primjenjuje vaginalno.
English: As for all medicines, data on the use of Senshio are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Senshio kontinuirano se prate.
English: What are the risks associated with Senshio?
Croatian: Koji su rizici povezani s lijekom Senshio?
English: Senshio must also not be used in women who have breast cancer or another cancer that is sex-hormone dependent such as endometrial cancer (cancer of the womb).
Croatian: Lijek Senshio također se ne smije primjenjivati u žena oboljelih od raka dojke ili drugih oblika raka koji su ovisni o spolnim hormonima, poput raka endometrija (rak maternice).
English: The company that markets Senshio is carrying out a study to further investigate long-term potential risks such as endometrial hyperplasia, stroke and venous thromboembolism.
Croatian: Tvrtka koja stavlja lijek Senshio u promet provodi ispitivanje kako bi se dodatno ispitali potencijalni dugoročni rizici kao što su hiperplazija endometrija, moždani udar i venska tromboembolija.
English: Senshio has been compared with placebo (a dummy treatment) in two main studies involving over 1,700 postmenopausal women with vulvovaginal atrophy.
Croatian: Lijek Senshio uspoređen je s placebom (prividnim liječenjem) u dvama glavnim ispitivanjima koja su obuhvatila 1 700 žena u postmenopauzi, koje su imale vulvovaginalnu atrofiju.
English: Regarding pain during sexual activity, 58% of women using Senshio reported relief in the first study (compared with 42% receiving placebo) and 63% reported relief during the second study (compared with 48% receiving placebo).
Croatian: Kad je riječ o bolu tijekom spolnih aktivnosti, 58 % žena koje su primale lijek Senshio prijavilo je ublažavanje simptoma u prvom ispitivanju (u usporedbi s 42 % žena u skupini koja je primala placebo), a 63 % žena prijavilo je ublažavanje simptoma tijekom drugog ispitivanja (u usporedbi s 48 % žena u skupini koja je primala placebo).
English: The Agency considered that the safety profile of Senshio, which was studied for up to 15 months, was in line with medicines working in a similar way (SERMs), but noted, however, that long-term use of SERMs might be associated with risks such as endometrial hyperplasia, stroke and venous thromboembolism and requested further studies to investigate these risks with Senshio.
Croatian: Agencija je smatrala da je sigurnosni profil lijeka Senshio, koji je ispitivan gotovo 15 mjeseci, bio u skladu s lijekovima koji djeluju na sličan način (selektivni modulatori estrogenskih receptora, SERM), ali je napomenula da dugoročna primjena selektivnih modulatora estrogenskih receptora može biti povezana s hiperplazijom endometrija, moždanim udarom i venskom tromboemolijom te je zatražila daljnja ispitivanja kako bi se ispitali navedeni rizici povezani s lijekom Senshio.
English: In addition, it must not be used in patients with unexplained vaginal bleeding or patients with endometrial hyperplasia (abnormal thickening of the lining of the womb).
Croatian: Osim toga, ne smije se primjenjivati u bolesnica s vaginalnim krvarenjem čiji uzrok nije poznat ili u bolesnica s hiperplazijom endometrija (abnormalnim zadebljanjem sluznice maternice).
English: The most commonly reported side effects with Senshio (affecting up to 1 in 10 people) are vulvovaginal candidiasis and other mycotic (fungal) infections, hot flushes, headache, muscle spasms, vaginal bleeding, vaginal and genital discharge, and rash.
Croatian: Najčešće zabilježene nuspojave lijeka Senshio (koje se javljaju u manje od 1 na 10 osoba) jesu vulvovaginalna kandidijaza i druge mikotične (gljivične) infekcije, navale vrućine, glavobolja, grčevi u mišićima, vaginalno krvarenje, vaginalni i genitalni iscjedak te osip.
English: Some women must not use Senshio, including those who have or have had problems with blood clots in veins such as deep-vein thrombosis (DVT), pulmonary embolism (a blood clot in the lungs) and retinal-vein thrombosis (a blood clot at the back of the eye).
Croatian: Neke žene se smiju primjenjivati lijek Senshio, uključujući one koje imaju ili su u prošlosti imale probleme s krvnim ugrušcima, kao što su duboka venska tromboza (DVT), plućna embolija (krvni ugrušak u plućima) i tromboza retinalne vene (krvni ugrušak na stražnjem dijelu oka).
English: Senshio is a medicine used to treat moderate to severe symptoms of vulvovaginal atrophy (dryness, irritation and soreness around the genital area, and painful sexual intercourse) in women who have been through the menopause.
Croatian: Senshio je lijek za liječenje umjerenih do teških simptoma vulvovaginalne atrofije (suhoće, iritacije i bola u genitalnom području, kao i bolnog spolnog odnosa) u žena koje su prošle menopauzu.
English: In the second study, 62% of women using Senshio reported relief from vaginal dryness after 12 weeks (compared with 53% in the placebo group).
Croatian: U drugom ispitivanju je 62 % žena koje su primale lijek Senshio prijavilo ublažavanje vaginalne suhoće nakon 12 tjedana (u usporedbi s 53 % žena u skupini koja je primala placebo).
English: Why is Senshio approved?
Croatian: Zašto je lijek Senshio odobren?
English: The Agency noted that the degree of improvement with Senshio was comparable to that with oestrogen treatments that are applied to the vagina.
Croatian: Agencija je napomenula da se stupanj ublažavanja simptoma zabilježen pri primjeni lijeka Senshio može usporediti s estrogenskim terapijama koje se primjenjuju vaginalno.
English: What benefits of Senshio have been shown in studies?
Croatian: Koje su koristi od lijeka Senshio utvrđene u ispitivanjima?
English: In the first study, 66% of women using Senshio reported relief from vaginal dryness (mild or no symptoms) after 12 weeks' treatment compared with 49% in the placebo group.
Croatian: U prvom ispitivanju 66 % žena prijavilo je ublažavanje vaginalne suhoće (blagi simptomi ili bez simptoma) nakon 12 tjedana liječenja, u usporedbi s 49 % žena u skupini koja je primala placebo.
English: How does Senshio work?
Croatian: Kako djeluje Senshio?
English: Senshio improved symptoms of vulvovaginal atrophy in postmenopausal women.
Croatian: Primjena lijeka Senshio utječe na ublažavanje simptoma vulvovaginalne atrofije u žena u postmenopauzi.
English: For the full list of side effects and restrictionsof Senshio, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja povezanih s lijekom Senshio potražite u uputi o lijeku.
English: This can cause irritation and soreness and make sexual intercourse painful.The active substance in Senshio, ospemifene, is a selective oestrogen receptor modulator (SERM).
Croatian: Djelatna tvar lijeka Senshio, ospemifen, selektivni je modulator estrogenskih receptora.
English: In the future, if the animals come into contact with the virus the immune system will be able to respond quickly to destroy the virus.
Croatian: Ako životinje u budućnosti budu izložene virusu, imunosni sustav moći će brzo reagirati i uništiti virus.
English: The full EPAR for Suvaxyn Circo can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za VMP Suvaxyn Circo nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: Infections can produce clinical signs such as weight loss or failure to grow, enlarged lymph nodes, difficulty breathing, pale skin and jaundice (yellowing of the skin).
Croatian: Infekcije mogu dovesti do kliničkih znakova kao što su gubitak tjelesne težine ili prestanak rasta, povećani limfni čvorovi, otežano disanje, blijeda koža i žutica (žuta boja kože).
English: This summary was last updated in December 2017.
Croatian: Sažetak je posljednji put ažuriran u 12. 2017.
English: This will help protect the pigs against porcine circovirus infections.
Croatian: To će pomoći pri zaštiti svinja od infekcija cirkovirusom svinja.
English: The vaccine contains small amounts of a protein from PCV2 that have been killed (inactivated) so that they do not cause disease.
Croatian: Cjepivo sadržava male količine proteina iz virusa PCV2 koji je umrtvljen (inaktiviran) kako ne bi doveo do pojave bolesti.
English: The most common side effects with Suvaxyn Circo (which may affect more than 1 in 10 animals) are a short-lived increase in body temperature during the first 24 hours after vaccination and swelling (generally no wider than 2 cm) at the injection site which may last for up to 2 days.
Croatian: Najčešće nuspojave VMP-a Suvaxyn Circo (mogu se javiti u više od 1 na 10 životinja) su kratkotrajno povećanje tjelesne temperature u prva 24 sata nakon cijepljenja i otekline (uglavnom ne šire od 2 cm) na mjestu injiciranja, koje mogu trajati do dva dana.
English: The purpose of these studies was to establish how long it took pigs to be fully protected and how long the protection against PCV2 lasted.
Croatian: Svrha je tih ispitivanja bila utvrditi razdoblje potrebno za postizanje potpune zaštite svinja i duljinu trajanja zaštite protiv virusa PCV2.
English: Suvaxyn Circo+MH RTU is already approved in the EU.
Croatian: VMP Suvaxyn Circo+MH RTU već je odobren u EU-u.
English: Protection lasted 23 weeks after vaccination for PCV2.
Croatian: Zaštita je trajala 23 tjedna nakon cijepljenja za PCV2.
English: Suvaxyn Circo also contains adjuvants (ingredients that strengthen the immune response) called squalane, poloxamer 401 and polysorbate 80.
Croatian: Suvaxyn Circo sadržava i adjuvanse (sastojke koji jačaju odgovor imunosnog sustava): skvalan, poloksamer 401 i polisorbat 80.
English: The withdrawal period for meat from pigs treated with Suvaxyn Circo is ‘zero' days, which means there is no mandatory waiting time.
Croatian: Razdoblje karencije za meso svinja liječenih VMP-om Suvaxyn Circo iznosi „nula” dana, drugim riječima, nema obveznog perioda čekanja.
English: When Suvaxyn Circo is given to pigs the animals' immune system recognises the viral protein as ‘foreign' and makes antibodies against it.
Croatian: Kada se Suvaxyn Circo daje svinjama, imunosni sustav životinje prepoznaje virusni protein kao „strano tijelo” te proizvodi protutijela protiv njega.
English: It is not intended to provide practical advice on how to use Suvaxyn Circo.
Croatian: Svrha sažetka nije davati praktične savjete o korištenju VMP-a Suvaxyn Circo.
English: The European Commission granted a marketing authorisation valid throughout the EU for Suvaxyn Circo on 7 February 2018.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za VMP Suvaxyn Circo na snazi u Europskoj uniji od 07/02/2018.
English: The studies showed that the vaccine had its full effect against PCV2 by three weeks after vaccination.
Croatian: Ispitivanja su pokazala da je cjepivo postiglo potpuni učinak protiv virusa PCV2 tri tjedna nakon cijepljenja.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Suvaxyn Circo's benefits are greater than its risks and recommended that it be approved for use in the EU.
Croatian: Odbor za veterinarsko-medicinske proizvode (CVMP) pri Agenciji odlučio je da koristi od VMP-a Suvaxyn Circo nadmašuju s njim povezane rizike te je preporučio njegovo odobrenje za primjenu u Europskoj uniji.
English: This is a summary of the European public assessment report (EPAR) for Suvaxyn Circo.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) o veterinarsko-medicinskom proizvodu Suvaxyn Circo.
English: Other information about Suvaxyn Circo
Croatian: Ostale informacije o VMP-u Suvaxyn Circo
English: The studies on the effectiveness of Suvaxyn Circo were carried out with a similar vaccine, Suvaxyn Circo+MH RTU, which contains PCV2 and the bacteria Mycoplasma hyopneumoniae.
Croatian: Ispitivanja djelotvornosti VMP-a Suvaxyn Circo provedena su sa sličnim cjepivom Suvaxyn Circo+MH RTU, koje sadržava PCV2 i bakteriju Mycoplasma hyopneumoniae.
English: Suvaxyn Circo porcine circovirus vaccine (inactivated)
Croatian: Suvaxyn Circo cjepivo protiv cirkovirusa svinja (inaktivirano)
English: Suvaxyn Circo, which is available as a liquid for injection, is given to pigs from three weeks of age as a single injection into the muscle in the neck behind the ear.
Croatian: Cjepivo Suvaxyn Circo, koje je dostupno u obliku tekućine za injekciju, daje se svinjama u dobi od tri tjedna i više u obliku jedne injekcije u mišić vrata iza uha.
English: Suvaxyn Circo is a veterinary vaccine used to protect pigs over the age of 3 weeks against porcine circovirus type 2 (PCV2).
Croatian: Suvaxyn Circo veterinarsko je cjepivo koje se primjenjuje za zaštitu svinja u dobi od tri tjedna i više od cirkovirusa svinja tipa 2 (PCV2).
English: What is Suvaxyn Circo and what is it used for?
Croatian: Što je Suvaxyn Circo i za što se koristi?
English: The effectiveness of Suvaxyn Circo+MH RTU was first studied in several laboratory studies in pigs.
Croatian: Djelotvornost VMP-a Suvaxyn Circo+MH RTU prvo je ispitana u okviru nekoliko laboratorijskih ispitivanja na svinjama.
English: Suvaxyn Circo is a vaccine.
Croatian: Suvaxyn Circo je cjepivo.
English: Why is Suvaxyn Circo approved?
Croatian: Zašto je Suvaxyn Circo odobren?
English: The field studies showed that Suvaxyn Circo reduced the PCV2 viraemia (presence of virus in the blood) compared to pigs given dummy vaccination.
Croatian: Terenska su ispitivanja pokazala da je primjenom cjepiva Suvaxyn Circo smanjena viremija (prisutnost virusa u krvi) virusa PCV2 u odnosu na svinje kojima je dano lažno cjepivo.
English: What are the risks associated with Suvaxyn Circo?
Croatian: Koji su rizici povezani s VMP-om Suvaxyn Circo?
English: Suvaxyn Circo contains an inactivated (killed) active substance derived from porcine circovirus type 2.
Croatian: Suvaxyn Circo sadržava inaktiviranu (umrtvljenu) djelatnu tvar dobivenu od cirkovirusa svinja tipa 2.
English: For the full list of restrictions and side effects with Suvaxyn Circo, see the package leaflet.
Croatian: Potpuni popis ograničenja i nuspojava zabilježenih pri primjeni VMP-a Suvaxyn Circo potražite u uputi o VMP-u.
English: For practical information about using Suvaxyn Circo, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Croatian: Praktične informacije o primjeni VMP-a Suvaxyn Circo vlasnici životinja ili uzgajivači trebaju pročitati u uputi o VMP-u, odnosno trebaju se obratiti svojem veterinaru ili ljekarniku.
English: For more information about treatment with Suvaxyn Circo, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Croatian: Dodatne informacije o terapiji VMP-om Suvaxyn Circo vlasnici životinja ili uzgajivači trebaju pročitati u uputi o VMP-u, odnosno trebaju se obratiti svojem veterinaru ili ljekarniku.
English: Suvaxyn Circo is only available on prescription.
Croatian: Suvaxyn Circo izdaje se samo na veterinarski recept.
English: How is Suvaxyn Circo used?
Croatian: Kako se Suvaxyn Circo koristi?
English: How does Suvaxyn Circo work?
Croatian: Kako djeluje Suvaxyn Circo?
English: What benefits of Suvaxyn Circo have been shown in studies?
Croatian: Koje su koristi VMP-a Suvaxyn Circo utvrđene u ispitivanjima?
English: This is usually achieved within a month.
Croatian: To se obično postiže u roku od mjesec dana.
English: This summary was last updated in 10-2016
Croatian: Sažetak je posljednji put ažuriran u: 10. 2016.
English: This helps to improve the symptoms of the disease.
Croatian: To pomaže u smanjenju simptoma bolesti.
English: Most patients were also taking vitamins B6 or B12, or folate.
Croatian: Većina bolesnika uzimala je i vitamine B6 ili B12 ili folat.
English: It should be dissolved fully in water, juice, milk, formula or food immediately before being taken.
Croatian: Prašak se treba u potpunosti otopiti u vodi, soku, mlijeku, adaptiranom mlijeku ili hrani tik prije primjene.
English: The aim of the treatment is to keep blood levels of homocysteine below 15 micromoles or as low as possible.
Croatian: Cilj liječenja je zadržati razinu homocisteina u krvi ispod 15 mikromola ili što niže.
English: The dose can be adjusted depending on the response to treatment (monitored by measuring the level of homocysteine in the blood).
Croatian: Doza se može prilagoditi ovisno o reakciji na liječenje (nadzire se mjerenjem razine homocisteina u krvi).
English: It is used with other treatments, such as vitamin B6 (pyridoxine), vitamin B12 (cobalamin), folate and a special diet.
Croatian: Primjenjuje se zajedno s drugim pripravcima kao što su vitamin B6 (piridoksin), vitamin B12 (kobalamin), folat i poseban način prehrane.
English: Cystadane is supplied with 3 measuring spoons to measure 100 mg, 150 mg and 1 g of the powder.
Croatian: Cystadane se isporučuje s 3 žličice s mjerom za 100 mg, 150 mg i 1 g praška.
English: The standard dose of Cystadane is 100 mg per kilogram of body weight a day, divided into two equal doses.
Croatian: Preporučena doza lijeka Cystadane je 100 mg dnevno po kilogramu tjelesne težine, podijeljeno u dvije jednake doze.
English: Other information about Cystadane
Croatian: Ostale informacije o lijeku Cystadane
English: What measures are being taken to ensure the safe and effective use of Cystadane?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Cystadane?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Cystadane on 15 February 2007.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet lijeka Cystadane u promet koje vrijedi na prostoru Europske unije od 15. veljače 2007.
English: In particular, the company will monitor cases of cerebral oedema, which was seen in a small number of patients during the testing of the medicine.
Croatian: Tvrtka će posebno nadzirati slučajeve cerebralnog edema koji je primijećen kod malog broja bolesnika tijekom ispitivanja lijeka.
English: This is a summary of the European public assessment report (EPAR) for Cystadane.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) lijeka Cystadane.
English: Betaine is a natural substance that is extracted from sugar beet.
Croatian: Betain je prirodna tvar koja se dobiva iz šećerne repe.